Each year, the Canadian Breast Cancer Foundation (CBCF) directs millions of dollars to breast cancer research and community projects through its granting programs. Our grant applications are peer-reviewed by a panel of experts to ensure that every donor dollar supports only the best and most promising breast cancer research and community projects. Ultimately, we believe that all of our cause-related investments take us closer to a future without breast cancer.
National Grant Competition
Stand Up To Cancer Canada – Canadian Breast Cancer Foundation
Breast Cancer Dream Team, supported by CIBC
(Administered by AACR International – Canada)
The Stand Up To Cancer Canada – Canadian Breast Cancer Foundation Breast Cancer Dream Team, supported by CIBC, represents a new focused effort to accelerate advances in breast cancer research through the creation of a collaborative, translational, research team pursuing the most promising science for a new breast cancer therapeutic intervention. The most talented and promising researchers across institutions will be assembled into a team of researchers forming an optimal configuration of expertise needed to solve key problems in breast cancer and positively impact patients in the near future. This SU2C Canada CBCF Breast Cancer Dream Team, supported by CIBC, will span multiple disciplines and utilize the new tools of modern biology to attack research questions in a coordinated way. Mechanisms to foster collaborations within and among the team of researchers will be employed – an approach that promotes the sharing of information and a goal-oriented focus on measurable milestones of progress. SU2C Canada and the Canadian Breast Cancer Foundation believe that this unique model will advance scientific research in the interests of both today’s cancer patients and those who may develop cancer in the future.
Total funds of nearly $9 million (CAD) are available from the funders. The investment will be awarded to a ‘Dream Team’ to be comprised of some of Canada’s top scientists across a variety of disciplines and institutions, selected for the best idea to accelerate research on a new treatment for breast cancer. This grant offers funding for a 4-year research term, depending upon project requirements, and will be contingent on the SU2C Canada Scientific Advisory Committee (CSAC) and the Breast Cancer Subcommittee finding that the funds are justified and that milestones and objectives have been appropriately selected and are being satisfactorily pursued and achieved. The funds must be used for research at Canadian institutions.
To focus the efforts of the Canadian research community on accelerating the pace of groundbreaking translational research that can get new breast cancer therapeutic interventions to patients.
To support the vision of the CBCF National Research Strategy of strengthening pan-Canadian breast cancer research in areas of strategic priority and high impact potential for patients.
The successful SU2C Canada CBCF Breast Cancer Dream Team, supported by CIBC will:
Develop a translational cancer research project that addresses critical problems in breast cancer patient care.
The project must include new anti-cancer therapeutic interventions for breast cancer that would be expected to improve progression free and/or overall survival, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic team of expert investigators (Therapeutics might include pharmaceuticals, biologics, vaccines, surgical interventions, and medical devices).
The Dream Team leadership (Leaders and Principals) involve institutions from a minimum of 3 different Provinces.
The project must be designed to accelerate the application of anti-breast cancer therapeutic interventions to the clinic (i.e., must include initiation of testing in human subjects within 3 years from the beginning of the research funding).
Ideas should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care.
||Tuesday, October 14, 2014|
|LOI Due Date:
||Monday, December 8, 2014 by 12:00pm EST |
|Full Proposals Due Date:
||Monday, April 27, 2015 by 12:00pm EST|
|Public Announcement of Results:
Due to the nature of the peer-review process, all LOI and application materials must be completed in English.
The amount available to support one Dream Team is up to $9 million (CAD) over 4 years. Of this:
This competition will be administered by American Association for Cancer Research International – Canada (AACR International – Canada). For more information on the competition and how to apply please visit AACR Canada website.
For more information please contact firstname.lastname@example.org